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ABSTRACT 
Neutropenia is characterized by a deficiency or reduction in 
the number of mature neutrophils circulating in the blood and 
increased susceptibility of the host to acquire infections. 
The aim of this article is to report the case of a child 
diagnosed with cyclic neutropenia of autosomal dominant type  
caused by mutation of the gene ELANE and emphasize the 
importance of pediatric dentistry in dental care for the oral 
health, since the diagnosis, prevention and maintenance of 
oral health. 
 
INTRODUCTION 
The term neutropenia is used to describe a group of 
diseases that presents a deficiency or decrease in the number 
of mature neutrophils circulating in the blood, therefore 
increasing the susceptibility of the host to acquire 
infections.1 Neutrophils are white blood cells, also known as 
differentiated leukocytes which form the first line of defense 
of the organism,2,3 making the most abundant population of 
leukocytes in the blood and participating in the first stages 
of the inflammatory response in the body.4 
In order to undergo the process of maturation and reach 
the bloodstream, neutrophils require nine to eleven days in 
physiological conditions.4,5After the maturation process, they 
start to circulate in the blood for a period of approximately 
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six to ten hours, and survive for up to 48 hours in inflamed 
tissues. Within that period, if they are not recruited to an 
inflamed site, they suffer apoptosis and phagocytosis by 
macrophages. During the inflammatory response of tissues, when 
they are recruited, neutrophils cluster on the surface of 
endothelial cells and reach the area of the inflamed tissue, 
causing the destruction of pathogenic agents.6 
Clinically, an individual affected by neutropenia may 
have recurrent infections, which are often fatal. The 
frequency and severity of infections depend on the count and 
speed of decline in the number of neutrophils, abnormalities 
of the phagocytic function, the deficits of adaptive immune 
function, host conditions and specific germ.7 
The neutropenia can be acquired or congenital(table 1) 
and regarding the severity, may be classified as mild (1,000 
to 1,500 neutrophils/mm3), moderate (500-1,000 neutrophils/mm3) 
or severe (< 500 neutrophils/mm3).4 
     The cyclic neutropenia was first described by Leale in 
1910, as autosomal dominant, a result from the mutation of the 
gene ELANE of the character position 13.3 of the short arm of 
chromosome 19 that codes the neutrophil elastase.9 Its 
prevalence is of 1-9 per 1,000,000.10 The disease is 
characterized by periods of neutropenia (< 1,000 
neutrophils/mm3) with a duration of three to ten days that are 
repeated at intervals of 21 days,11 and may vary from 14-36 
days. During neutropenia it can be observed fever, malaise, 
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periodontal disease, ulceration of the oral mucosa, impetigo 
and lymphadenopathy, common symptoms in children and 
adolescents. Whereas adults have mild-to-moderate neutropenia 
without well-defined cycles. Some complications such as 
cellulitis, necrotizing enterocolitis and bacteremia are 
severe and can be fatal.12 
Oral manifestations, such as ulcers, periodontal disease, 
tooth mobility and early tooth loss are common signs in 
patients with congenital neutropenia.13 The diagnosis of 
congenital neutropenia is suspected in children with recurrent 
oral infection and persistent bacterial or fungal infection.14 
For the diagnosis of cyclic neutropenia, it is necessary 
to perform complete blood count (twice a week for six weeks) 
and bone marrow examination.14 
In the 1980s, the granulocyte colony-stimulating factor 
(rHUG-CSF) was introduced in the treatment of neutropenic 
patients, increasing the number of circulating neutrophils and 
stimulating the proliferation, differentiation and maturation 
of precursor cells of neutrophils, reducing the frequency and 
severity of infections, with a prognosis resulting in a better 
quality of life for the treatment of patients with 
neutropenia.15,16 
Another form of treatment is transplantation of 
hematopoietic system cells. In addition to these treatments, 
the prophylaxis, which consists of the use of broad spectrum 
antibiotics, has been recommended.17 However, many patients 
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still suffer due to the disease disorders.18 The objective of 
this work is to report the case of a child with cyclic 
neutropenia, addressing etiology, diagnosis, clinical aspects, 
oral manifestations and treatment, as well as dental care in 
the treatment of these patients. 
 
CASE REPORT 
Patient, female, caucasian, attended the Clinic for 
babies from Pediatric Dentistry from the School of Dentistry 
of Federal University of Uberlândia, accompanied by her 
mother, who consented to have the case was described in this 
report. At the first child’s dental care service, the she was 
13 months old. In the anamnesis, the evaluation of the medical 
history revealed that there were no complications during 
pregnancy, it was cesarean, the child was born at term, with 
5,76 lbs and 46 cm, without any change originating from 
complications during the labor work. Up to 12 months, the 
child had never been hospitalized, but had already presented 
respiratory problems (bronchiolitis) at three months and 
frequent cases of tonsillitis, with use of antibiotics. 
Regarding the food habits, the child was breastfed just in the 
first month, used with some frequency pasty feed and tooth 
brushing was performed by parents on average twice a day, with 
some difficulty, due to the child’s behavior. 
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During extra-oral clinical examination, no alterations 
were found and the intra-oral revealed eruption of deciduous 
teeth that were compatible with the age of the child (upper 
and lower erupted incisors), ankyloglossia and absence of 
caries lesions. In the follow-up, after four months, the 
mother reported as main complaint bleeding during brushing. 
During the clinical examination, it was noted gingival edema, 
inflamed marginal gingiva, presence of dental visible biofilm, 
calculus on the proximal faces of the lower anterior teeth 
(Figure 1), and presence of ulceration on the oral mucosa, 
suggesting the presence of canker sore (Figure 2).                                  
Professional prophylaxis with Robinson toothbrush and 
toothpaste was performed and the child was scheduled to return 
monthly for dental biofilm control and gingivitis (Figure 3). 
For the removal of calculus, found in the anterior teeth 
proximal, exploratory probe was used and strip of sandpaper 
for resin finishing between the teeth to complete the calculus 
removal. However, in subsequent follow-ups there was no 
improvement in gingival bleeding and even after new sessions 
of prophylaxis, the gum was still reddish in color, with the 
presence of gingival bleeding during brushing even with a 
reduction of the biofilm. 
Thus, before the clinical conditions, medical opinion was 
requested and the child was referred for examination at the 
medical clinic, at 24 months old. According to medical report, 
the child had neutropenia in laboratory examinations and 
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during investigation was observed severe neutropenia (below 
500) at certain times. In addition, usually the child is 
affected by recurrent infections characterized by tonsillitis, 
boils in the genital region and gingivostomatitis, with 
frequent use of antibiotics (approximately twice or more per 
month). Due to the fact aforementioned, prophylactic 
antibiotic of wide spectrum was started in an attempt to 
maintain the child free from infectious processes, but, even 
so, she showed persistent infection signs. Other immunological 
parameters were within normal levels for her age. In this case 
for the diagnosis of the type of neutropenia, complete blood 
counts were performed (twice a week, on Tuesdays and Fridays 
for six weeks) and bone marrow examination that allowed to 
define the diagnosis of cyclic neutropenia at three years of 
age.  
Thus, for the dental treatment, the child is being 
accompanied at the pediatric dentistry clinic once a month for 
mechanical control of dental biofilm, and now with evident 
improvement of the gingival condition and continues without 
any tooth decay.  
 
DISCUSSION 
The dental surgeons play an important role in early 
detection of diseases in the oral cavity, due to initial signs 
that can be observed in the clinical examination.19 
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During the early childhood, it is important that the 
pediatric dentistrylearns to diagnose and treat oral 
manifestations whenever necessary, because the infants exhibit 
unique and transitory anatomical structures typical of this 
phase. It should be emphasized that children with systemic 
changes are 17.4 times more likely to have oral manifestations 
compared to those without systemic changes.20And although 
changes in the mucosa are relatively common in children, oral 
severe disorders are associated with medical conditions.21So in 
the case described, the persistence of the gingivitis, even 
with professional control of biofilm was the aspect that 
attracted the attention to investigate the child’s systemic 
conditions. In another case report 6-year-old child, changes 
in the oral cavity as recurrent oral ulcers, gingival 
recession, gingivitis, tooth mobility were the signs that led 
to the diagnosis of cyclic neutropenia.22 
Periodontal disease is an inflammatory process of 
infectious origin which affects the gingival tissues and/or 
the tissue supporting the teeth,23 occurring as a result of 
inflammatory reactions and immune responses in periodontal 
tissues induced by micro-organisms of the biofilm, damaging 
the connective tissue and alveolar bone.24,25The deficiency of 
host response in individuals with congenital neutropenia can 
obstruct the interaction between the host and the microbial 
flora. Thus, the deficiency of neutrophils increases the risk 
of infections, as well as periodontal disease.26 Although the 
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periodontal disease appears as a response of the gums to the 
formation of biofilm and calculus, it is also recognized that 
this response can be modified by systemic factors. The 
persistent gingivitis exhibited by the child in this case can 
be attributed to the reduction of neutrophils, because even 
with the frequent sessions of professional prophylaxis 
improvement was not found in the bleeding and redness of the 
gum tissue of the patient.27 
 The periodontal manifestations found are related to the 
degree of neutropenia. Mild cases may lead to the appearance 
of changes in gingival tissues, with the appearance of 
ulcerative gingivitis, characterized by the presence of 
redness, bleeding, ulcers and pain.28In severe cases, it can 
affect the tissues supporting the teeth, bone loss and bag 
formation, characterized as an aggressive periodontitis.29 
The main objective of the periodontal treatment for 
patients with neutropenia, must be the prevention through 
control of biofilm and odontological follow-up.30 Therefore, 
the fact that the mother has sought dental care to thirteen 
months of age and participate actively in the child’s oral 
hygiene, was fundamental so that the gingivitis did not 
worsen. And after the systemic treatment, it was also possible 
to observe the improvement in the gingivitis condition’ 
simultaneously. Unlike the report presented of a child 
diagnosed at 6 years old, in which despite the systemic 
treatment used, the irregularity of periodontal conditions 
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maintenance, led to the persistence of gingival inflammation 
and deep periodontal pocketsin the permanent dentition.22 
Thus, periodic evaluations with the dental surgeon, along 
with a patient motivated to perform a good oral hygiene, are 
the best way to prevent diseases of the oral cavity.31 In 
addition, regular visits to the dental office for monitoring 
and control of dental biofilm, contribute to improving both 
the oral health, as the patient’s systemic condition.30,32 
Some preventive strategies and treatment were developed 
for neutropenic patients who suffer with some changes in the 
oral cavity and according to Olvera et al.(2015), 
consultations with a pediatrician for checking the current 
status of the patient and recent counts of defense cells to 
check the number, variety, concentration and quality of blood 
cells should be performed, because it is important to know the 
normal values of groups of cells to know when they can make an 
oral rehabilitation with safety and without complications. And 
to avoid complications,according to Olvera et al.(2015) it is 
important to follow a prophylactic scheme with antibacterial 
basis, amoxicillin 50mg/kg or clindamycin 100mg/kg in the case 
of allergy, to avoid infectious processes, using it as a 
therapeutic regimen (every eight hours for seven days) when 
the consultations are consecutively or as a prophylactic 
scheme (one hour before beginning the dental treatment, in a 
single dose) when treating emergency or isolated 
consultations. Check the total number of neutrophils before 
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and after the treatment is a good alternative to monitor the 
condition of the patient’s neutropenia. 
Therefore, preventive strategies for control of biofilm 
by brushing after every meal, implement the use of dental 
floss, adequate nutrition, regular consultations with the 
pediatrician and follow-up by means of exams for knowledge of 
the count of neutrophils in the blood, applying the 
stimulating factor of colonies, mouth wash with chlorhexidine 
twice per day, systemic antibiotics and regular consultations 
with the surgeon-dentist to better oral hygiene, are important 
measures in order to improve the oral condition of these 
patients.9 
In the case of the patient, who at the time of the first 
dental examination was 13 months old, the mouth wash with 
chlorhexidine was not recommended, and in subsequent 
consultations when there was an improvement in the gingivitis 
conditions, the application of chlorhexidine was performed 
with sterile gauze on the tooth surfaces and gingival region 
by the dental surgeon on the day of the dental care. Although 
the susceptibility of an individual to periodontal disease is 
influenced by many factors, such as systemic and genetic 
diseases, the evidence indicates that prevention of gingival 
inflammation by controlling the dental biofilm reduces the 
severity of such conditions in this group of patients.27 
The majority of patients with cyclic neutropenia during 
the outbreaks of neutropenia and associated infections are 
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treated with antibiotics or immunoglobulin for intravenous 
administration (IVIG). In severe cases, the treatment consists 
of the use of Granulocyte colony-stimulating factor (rHUG-CSF) 
in symptomatic patients,12 increasing the neutrophil count for 
more than 1,000 neutrophils/mm3. Although most patients do not 
require rHUG-CSF, in serious cases of non-responsive Cyclic 
neutropenia to therapy with rHUG-CSF the bone marrow 
transplant is indicated.33 In the case of the patient, the 
option of treatment proposed by physicians was the injectable 
medication (Filgrastim 300mcg three times a week), which is a 
Granulocyte colony-stimulating factor, with the purpose of 
inducing the production of neutrophils, thereby improving the 
children’ life quality and the morbimortality.  In a case of 
an 8-year-old patient, also treated with Filgrastim, the 
authors reported that there was an improvement in the child’s 
overall health, but the damage caused to the periodontal 
tissues could not be re-established, however, the progression 
of periodontal disease was interrupted, and it was possible 
the oral health maintenance by means of periodic follow-ups 
and use of chlorhexidine 0.2% in episodes of neutropenia.34 
According to the medical guidance, the child will make 
use of the medication until 10 years old, because during this 
period of puberty there may be a natural increase in the 
numbers of neutrophils, no longer being necessary the use of 
medication. Therefore, there will be a follow-up to determine 
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the interruption of medication or a new treatment strategy, if 
the increase in neutrophils do not happen as expected. 
Thus, the dental surgeons who diagnose gingival inflammation 
and periodontal disease in children apparently healthy should 
direct these patients to a pediatric clinic for evaluation. 
The odontological prevention and follow-up of neutropenia 
patients should be emphasized, it is important to carry out 
mechanical control of dental biofilm, removal of calculus, 
prevention of dental caries, orientation of oral hygiene in 
addition to adequate nutrition. Parents should be encouraged 
to actively participate in these preventive activities.       
 
CONCLUSION 
It was possible to confirm the importance of the role of the 
pediatric dentist since the diagnosis, prevention and 
maintenance of oral health in patients with cyclic neutropenia 
diagnosed during childhood. 
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TABLE 
 
Table 1: Classification of neutropenias.8 
Congenital Neutropenias   Acquired Neutropenias 
Isolated congenital 
Neutropenias 
Neutropenia as isolated or 
dominant citopenia 
Syndrome of kostmann and 
congenital severe neutropenia 
Infections: viruses, 
bacteria, fungi, rickettsia 
and protozoal infections 
Cyclic neutropenia Drugs 
Benign family Neutropenia Immune 
Neutropenia in the context of 
syndromes of congenital 
medullary insufficiency 
Infancy primary autoimmune 
Neutropenia 
(Syndrome of Shwachman -
Diamond, Fanconi's anemia, 
congenital dyskeratosis, 
etc.)  
Autoimmune secondary 
neutropenia  
Congenital Neutropenia as 
part of multisystem disorder  
Nutrition: anorexia nervosa, 
copper deficiency 
Barth’s syndrome Idiopathic chronic 
Neutropenia 
Pearson’s syndrome Neutropenia associated with 
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complement activation 
Glycogenosis type Ib Neutropenia as part of 
pancytopenia 
Congenital Neutropenia in 
association with adaptive 
immunity defects  
Acquired bone marrow failure 
(Aplastic anemia, medullar 
infiltration, etc.) 
Severe combined 
immunodeficiency (SCID) and 
reticular dysgenesis 
Nutritional deficiency 
(deficit of vitamin B12 and 
folic acid) 
Hypogammaglobinemia 
associated with X 
Splenic sequestration 
Syndrome of Hyper-IgM  
Syndrome of WHIM and 
mielocataxe 
 
 
 
 
 
 
 
 
 
26 
 
 
FIGURE 1 
                  
 
 
FIGURE 2 
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FIGURE 3 
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FIGURE LEGENDS 
Figure 1. Intraoral clinical examination showing  inflamed 
marginal gingiva and presence of dental calculus on the 
proximal faces of the lower anterior teeth. 
 
Figure 2. Intraoral clinical examinationshowing the presence 
of ulceration on the oralmucosa. 
 
Figure 3. Professional prophylaxis. 
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APPENDIX 
SPECIAL CARE IN DENTISTRY 
Author Guidelines 
The mission of Special Care in Dentistry (SCD) is to provide a 
forum for research findings, case reports, clinical techniques 
and scholarly discussion relevant to the oral health and oral 
health care of “special care patients.” The designation of the 
special care patient is not limited to hospitalized, disabled 
or older individuals, but includes all patients for whom oral 
health and oral health care are complicated by physical, 
emotional, financial and/or access factors. 
Effective with the 2015 volume, this journal will be published 
in an online-only format. 
Manuscripts 
Original articles are considered and accepted for publication 
on the condition that they have not been published or are not 
simultaneously submitted for publication elsewhere. A letter 
signed by all authors stating that the submission is an 
original article, not previously published or simultaneously 
being considered for publication elsewhere, must accompany the 
submission. 
All manuscripts should be submitted through the online 
submission system at http://mc.manuscriptcentral.com/scid. 
The manuscript should be submitted with all material 
doublespaced, flush left (preferably in Courier typeface), 
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with at least a 1” margin all around. All pages should be 
systematically numbered. The editor reserves the right to edit 
manuscripts to fit available space and to ensure conciseness, 
clarity and stylistic consistency. 
Title page 
Titles of articles should be descriptive but concise. Long 
titles discourage reading, present typographic and layout 
problems and create difficulties in indexing. 
Include with the manuscript an abbreviated title (no more than 
50 characters including punctuation and spaces) to be used on 
the journal cover. On the title page please include no more 
than 6 keywords for the article. The corresponding author 
should include his or her E-mail address, daytime telephone 
and FAX numbers, as well as current address. Positions and 
professional degrees should be provided along with each 
author’s full first and last names. 
Abstract 
A brief structured abstract not to exceed 150 words must be 
included with each article and should state the following: 
purpose/aim of the article, the method and materials used, 
results and conclusions or clinical relevance. 
Scientific Article Content 
A critical review of the manuscript topic, the rationale and 
significance of the study and as appropriate study aims and/or 
hypotheses should be presented in the introduction. 
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Methods 
All methods used must be detailed, referenced adequately and 
include a description of the statistical data analysis 
methods. 
Results 
Results must be presented in a logical order with references 
to appropriate tables, figures and illustrations. 
Discussion 
Important findings from the study should be discussed and 
compared with the published literature on the topic. 
Limitations of the study and any future research implications 
of the study findings must be discussed. 
Conclusions 
Conclusions should be presented in sentence form and not as a 
numerical list or dot points. Conclusions should parallel 
those presented in the structured abstract. 
Case Report Content 
Case reports should be concise and do not need to be as 
formally structured as scientific articles. Include a brief 
introduction presenting a critical literature review and a 
statement of the clinical implications of the case. The case 
description should include: personal history of the subject, 
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